{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:21:54Z","timestamp":1794547314569,"version":"4.9.1"},"reference-count":90,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271307"],"award-info":[{"award-number":["32271307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR5RA520"],"award-info":[{"award-number":["22JR5RA520"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["26JRRA185"],"award-info":[{"award-number":["26JRRA185"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["26JRRA304"],"award-info":[{"award-number":["26JRRA304"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Qingyang","award":["QY-STK-2023B-120"],"award-info":[{"award-number":["QY-STK-2023B-120"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Long-term opioid analgesia is limited by severe adverse effects. We propose an auto-antagonistic multitarget strategy incorporating NPFFR2-mediated counter-regulation to limit excessive opioid effects while preserving analgesia. Structure-guided optimization of MCRT yielded analogs 1, 4, and 9, which function as MOR\/DOR\/NPFFR2 triple agonists. Analog 1 provided pharmacological proof-of-concept, exhibiting characteristic bell-shaped antinociceptive and gastrointestinal dose\u2212response profiles sensitive to RF-9 blockade. Together with its NPFFR2 agonism and no detectable NPFFR1 agonism in vitro, these findings support a contribution of NPFFR2-mediated counter-regulation to its self-limiting profile. In contrast, analogs 4 and 9 displayed dose-dependent analgesia and distinct in vivo profiles. All three analogs produced robust antinociception in CFA-induced inflammatory pain and showed no detectable tolerance or persistent gastrointestinal inhibition during repeated treatment, while analogs 1 and 4 showed no detectable withdrawal, conditioned place preference, or motor impairment. These findings support the auto-antagonistic strategy as a framework for developing safer analgesics.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c02406","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:06:42Z","timestamp":1790694402000},"page":"22972-22992","source":"Crossref","is-referenced-by-count":0,"title":["An Innovative Auto-Antagonistic Multi-Target Strategy: MOR\/DOR\/NPFFR2 Agonists Achieve Separation of Analgesia from Side Effects"],"prefix":"10.1021","volume":"69","author":[{"given":"Pengtao","family":"Li","sequence":"first","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yang","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lechun","family":"Ma","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyu","family":"Niu","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Bao","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkun","family":"Liu","sequence":"additional","affiliation":[{"name":"Longdong University , , , ,","place":["Qingyang, Gansu, China, 745000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmin","family":"Huang","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Man","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-7797","authenticated-orcid":true,"given":"Shouliang","family":"Dong","sequence":"additional","affiliation":[{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]},{"name":"Lanzhou University , , 222 Tianshui South Road , ,","place":["Lanzhou, China, 730000"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2026100811064523700_cit1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076036","article-title":"Chronic pain: definitions and diagnosis","volume":"381","author":"Kang","year":"2023","journal-title":"BMJ"},{"key":"2026100811064523700_cit2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/jama.2018.16009","article-title":"Chronic pain prevalence","volume":"320","author":"Kuehn","year":"2018","journal-title":"JAMA"},{"key":"2026100811064523700_cit3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.13563","article-title":"Estimated Rates of Incident and Persistent Chronic Pain Among US Adults, 2019-2020","volume":"6","author":"Nahin","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026100811064523700_cit4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/s0140-6736(25)00404-0","article-title":"Opportunities for chronic pain self-management: core psychological principles and neurobiological underpinnings","volume":"405","author":"Vase","year":"2025","journal-title":"Lancet"},{"key":"2026100811064523700_cit5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3322\/caac.21823","article-title":"Opioid analgesics for nociceptive cancer pain: A comprehensive review","volume":"74","author":"Abdel Shaheed","year":"2024","journal-title":"Ca-Cancer J. Clin."},{"key":"2026100811064523700_cit6","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1021\/acschemneuro.7b00195","article-title":"Novel Opioid Analgesics and Side Effects","volume":"8","author":"Del Vecchio","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"2026100811064523700_cit7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"2026100811064523700_cit8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"2026100811064523700_cit9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid Receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"2026100811064523700_cit10","doi-asserted-by":"publisher","first-page":"107408","DOI":"10.1016\/j.phrs.2024.107408","article-title":"Multitarget ligands that comprise opioid\/nonopioid pharmacophores for pain management: Current state of the science","volume":"209","author":"Breault","year":"2024","journal-title":"Pharmacol. Res."},{"key":"2026100811064523700_cit11","doi-asserted-by":"publisher","first-page":"107519","DOI":"10.1016\/j.pharmthera.2020.107519","article-title":"Replacement of current opioid drugs focusing on MOR-related strategies","volume":"210","author":"Busserolles","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"2026100811064523700_cit12","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s41401-021-00761-x","article-title":"Novel selective \u03ba agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion","volume":"43","author":"Wei","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"2026100811064523700_cit13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-pharmtox-052120-091058","article-title":"Biased Agonism: Lessons from Studies of Opioid Receptor Agonists","volume":"63","author":"Kelly","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2026100811064523700_cit14","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1097\/j.pain.0000000000001968","article-title":"Uncovering the analgesic effects of a pH-dependent mu-opioid receptor agonist using a model of nonevoked ongoing pain","volume":"161","author":"Massaly","year":"2020","journal-title":"Pain"},{"key":"2026100811064523700_cit15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejmech.2015.11.028","article-title":"Multitarget opioid ligands in pain relief: New players in an old game","volume":"108","author":"Turnaturi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"2026100811064523700_cit16","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1021\/acs.jmedchem.2c01695","article-title":"Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects","volume":"66","author":"Smith","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026100811064523700_cit17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/j.pain.0000000000003026","article-title":"How do opioids control pain circuits in the brainstem during opioid-induced disorders and in chronic pain? Implications for the treatment of chronic pain","volume":"165","author":"Costa","year":"2024","journal-title":"Pain"},{"key":"2026100811064523700_cit18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s44158-024-00201-2","article-title":"Opioid system and related ligands: from the past to future perspectives","volume":"4","author":"Rullo","year":"2024","journal-title":"J Anesth Analg Crit Care"},{"key":"2026100811064523700_cit19","doi-asserted-by":"publisher","first-page":"102528","DOI":"10.1016\/j.coph.2025.102528","article-title":"Delta opioid receptors: Overlooked outlier or the next big thing","volume":"83","author":"El Daibani","year":"2025","journal-title":"Curr. Opin. Pharmacol."},{"key":"2026100811064523700_cit20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejphar.2008.11.004","article-title":"Role of delta opioid efficacy as a determinant of mu\/delta opioid interactions in rhesus monkeys","volume":"602","author":"Negus","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"2026100811064523700_cit21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fphar.2019.00283","article-title":"Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated","volume":"10","author":"Polo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"2026100811064523700_cit22","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1124\/jpet.103.056515","article-title":"Opioid Interactions in Rhesus Monkeys: Effects of \u03b4 + \u03bc and \u03b4 + \u03ba Agonists on Schedule-Controlled Responding and Thermal Nociception","volume":"307","author":"Stevenson","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026100811064523700_cit23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1124\/jpet.302.1.188","article-title":"Profound spinal tolerance after repeated exposure to a highly selective \u03bc-opioid peptide agonist: role of \u03b4-opioid receptors","volume":"302","author":"Zhao","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026100811064523700_cit24","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1111\/bph.12857","article-title":"\u03b4-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes","volume":"171","author":"Liang","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"2026100811064523700_cit25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.14336\/ad.2022.0912","article-title":"\u03b4-opioid Receptor, Microglia and Neuroinflammation","volume":"14","author":"Xu","year":"2023","journal-title":"Aging Dis."},{"key":"2026100811064523700_cit26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/bja\/aer377","article-title":"Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505)","volume":"108","author":"Dietis","year":"2012","journal-title":"Br. J. Anaesth."},{"key":"2026100811064523700_cit27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpain.2019.05.017","article-title":"A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models","volume":"21","author":"Lei","year":"2020","journal-title":"J. Pain"},{"key":"2026100811064523700_cit28","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.1007\/s12035-019-1607-1","article-title":"Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain","volume":"56","author":"Vicario","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"2026100811064523700_cit29","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1021\/acs.jmedchem.0c00643","article-title":"Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development","volume":"63","author":"Nguyen","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026100811064523700_cit30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1476-5381.2011.01563.x","article-title":"Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments","volume":"165","author":"Elhabazi","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"2026100811064523700_cit31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbr.2013.03.046","article-title":"Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice","volume":"248","author":"Han","year":"2013","journal-title":"Behav. Brain Res."},{"key":"2026100811064523700_cit32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ejp.814","article-title":"Altered nociception and morphine tolerance in neuropeptide FF receptor type 2 over-expressing mice","volume":"20","author":"Lin","year":"2015","journal-title":"Eur. J. Pain"},{"key":"2026100811064523700_cit33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neulet.2014.10.018","article-title":"Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions","volume":"584","author":"Malin","year":"2015","journal-title":"Neurosci. Lett."},{"key":"2026100811064523700_cit34","doi-asserted-by":"publisher","first-page":"176457","DOI":"10.1016\/j.ejphar.2024.176457","article-title":"The blockade of neuropeptide FF receptor 1 and 2 differentially contributed to the modulating effects on fentanyl-induced analgesia and hyperalgesia in mice","volume":"969","author":"Chen","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"2026100811064523700_cit35","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1111\/bph.70178","article-title":"A novel peptide-fentanyl conjugate with \u03bc-opioid and neuropeptide FF receptor agonism produces antinociception with limited side effects in male mice","volume":"182","author":"Li","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"2026100811064523700_cit36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.regpep.2012.08.008","article-title":"Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide","volume":"179","author":"Li","year":"2012","journal-title":"Regul. Pept."},{"key":"2026100811064523700_cit37","doi-asserted-by":"publisher","first-page":"117389","DOI":"10.1016\/j.biopha.2024.117389","article-title":"Intrathecal administration of MCRT produced potent antinociception in chronic inflammatory pain models via \u03bc-\u03b4 heterodimer with limited side effects","volume":"179","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"2026100811064523700_cit38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"2026100811064523700_cit39","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/biom12091241","article-title":"Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery","volume":"12","author":"Lee","year":"2022","journal-title":"Biomolecules"},{"key":"2026100811064523700_cit40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/1389557023405567","article-title":"Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues-selective \u03bc-opioid receptor ligands","volume":"2","author":"Janecka","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"2026100811064523700_cit41","doi-asserted-by":"publisher","first-page":"116160","DOI":"10.1016\/j.celrep.2025.116160","article-title":"Structural basis of peptide recognition and modulation for neuropeptide FF receptors","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep."},{"key":"2026100811064523700_cit42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.peptides.2007.12.005","article-title":"[Dmt 1, D-1-Nal3] morphiceptin , a novel opioid peptide analog with high analgesic activity","volume":"29","author":"Fichna","year":"2008","journal-title":"Peptides"},{"key":"2026100811064523700_cit43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.peptides.2010.04.018","article-title":"Synthesis and biological evaluation of novel peripherally active morphiceptin analogs","volume":"31","author":"Gach","year":"2010","journal-title":"Peptides"},{"key":"2026100811064523700_cit44","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1021\/jm061238m","article-title":"Bifunctional [2\u2019, 6\u2019-Dimethyl-L-tyrosine] endomorphin-2 Analogues Substituted at Position 3 with Alkylated Phenylalanine Derivatives Yield Potent Mixed \u03bc-Agonist\/\u03b4-Antagonist and Dual \u03bc-Agonist\/\u03b4-Agonist Opioid Ligands","volume":"50","author":"Li","year":"2007","journal-title":"J. Med. Chem."},{"key":"2026100811064523700_cit45","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/ph14111091","article-title":"Opioid Analgesia and Opioid-Induced Adverse Effects: A Review","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026100811064523700_cit46","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.tips.2020.09.009","article-title":"Critical Assessment of G Protein-Biased Agonism at the \u03bc-Opioid Receptor","volume":"41","author":"Gillis","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"2026100811064523700_cit47","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.lfs.2009.02.025","article-title":"Bi- or multifunctional opioid peptide drugs","volume":"86","author":"Schiller","year":"2010","journal-title":"Life Sci."},{"key":"2026100811064523700_cit48","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.apsb.2025.11.039","article-title":"Mechanistic insights into ligand selectivity in \u03bc- and \u03b4-opioid receptors beyond the \u201cmessage-address\u201d conceptual framework","volume":"16","author":"Zhang","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"2026100811064523700_cit49","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"},{"key":"2026100811064523700_cit50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/bip.10399","article-title":"Dmt and opioid peptides: A potent alliance","volume":"71","author":"Bryant","year":"2004","journal-title":"Pept. Sci."},{"key":"2026100811064523700_cit51","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.cell.2009.04.019","article-title":"Dissociation of the opioid receptor mechanisms that control mechanical and heat pain","volume":"137","author":"Scherrer","year":"2009","journal-title":"Cell"},{"key":"2026100811064523700_cit52","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1124\/pr.114.008979","article-title":"Molecular Pharmacology of \u03b4-Opioid Receptors","volume":"68","author":"Gendron","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"2026100811064523700_cit53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1744-8069-9-8","article-title":"Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels","volume":"9","author":"Pradhan","year":"2013","journal-title":"Mol. Pain"},{"key":"2026100811064523700_cit54","doi-asserted-by":"publisher","first-page":"G544","DOI":"10.1152\/ajpgi.00025.2018","article-title":"Inflammation-associated changes in DOR expression and function in the mouse colon","volume":"315","author":"DiCello","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2026100811064523700_cit55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0304-3959(02)00333-0","article-title":"Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control","volume":"101","author":"Cahill","year":"2003","journal-title":"Pain"},{"key":"2026100811064523700_cit56","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1021\/acs.jmedchem.5b01976","article-title":"Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain","volume":"59","author":"Guillemyn","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026100811064523700_cit57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/med.20197","article-title":"Development of nociceptin receptor (NOP) agonists and antagonists","volume":"31","author":"Mustazza","year":"2011","journal-title":"Med. Res. Rev."},{"key":"2026100811064523700_cit58","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1124\/jpet.109.156711","article-title":"Nociceptin\/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin\/orphanin FQ\/mu-opioid receptor agonists","volume":"331","author":"Khroyan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026100811064523700_cit59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates","volume":"10","author":"Ding","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"2026100811064523700_cit60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrc.2005.08.060","article-title":"Anti-analgesia of a selective NPFF2 agonist depends on opioid activity","volume":"336","author":"Roussin","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026100811064523700_cit61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0167-0115(95)00091-o","article-title":"Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis","volume":"59","author":"Dupouy","year":"1995","journal-title":"Regul. Pept."},{"key":"2026100811064523700_cit62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.expneurol.2017.02.003","article-title":"Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice","volume":"291","author":"Lin","year":"2017","journal-title":"Exp. Neurol."},{"key":"2026100811064523700_cit63","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1021\/acs.jmedchem.4c00442","article-title":"Multitarget \u03bc-Opioid Receptor Agonists\u2212Neuropeptide FF Receptor Antagonists Induce Potent Antinociception with Reduced Adverse Side Effects","volume":"67","author":"De Neve","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026100811064523700_cit64","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1097\/j.pain.0000000000001262","article-title":"A bifunctional-biased mu-opioid agonist\u2212neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects","volume":"159","author":"Drieu la Rochelle","year":"2018","journal-title":"Pain"},{"key":"2026100811064523700_cit65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via \u03bc- and \u03ba-opioid receptors","volume":"177","author":"Xu","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"2026100811064523700_cit66","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1021\/acschemneuro.2c00442","article-title":"OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid\/Neuropeptide FF Receptors with Improved Blood\u2212Brain Barrier Penetration","volume":"13","author":"Zhang","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"2026100811064523700_cit67","doi-asserted-by":"publisher","first-page":"173169","DOI":"10.1016\/j.ejphar.2020.173169","article-title":"Spinal administration of the multi-functional opioid\/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia","volume":"880","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"2026100811064523700_cit68","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1074\/jbc.m606946200","article-title":"Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity","volume":"282","author":"Roumy","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2026100811064523700_cit69","doi-asserted-by":"publisher","first-page":"12736","DOI":"10.1074\/jbc.m111.314617","article-title":"GRK2 protein-mediated transphosphorylation contributes to loss of function of \u03bc-opioid receptors induced by neuropeptide FF (NPFF2) receptors","volume":"287","author":"Moule\u0301dous","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2026100811064523700_cit70","doi-asserted-by":"publisher","first-page":"154239","DOI":"10.1016\/j.tetlet.2022.154239","article-title":"Gram-scale preparation of DAMGO by typical solid phase synthesis","volume":"112","author":"Chen","year":"2022","journal-title":"Tetrahedron Lett."},{"key":"2026100811064523700_cit71","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1016\/j.bmc.2011.03.057","article-title":"Development of target protein-selective degradation inducer for protein knockdown","volume":"19","author":"Itoh","year":"2011","journal-title":"Biorg. Med. Chem."},{"key":"2026100811064523700_cit72","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Academies Press: Washington, DC, USA, 2011."},{"key":"2026100811064523700_cit73","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"2026100811064523700_cit74","doi-asserted-by":"publisher","first-page":"117225","DOI":"10.1016\/j.taap.2025.117225","article-title":"Peripheral inflammation enhances opioid-induced gastrointestinal motility inhibition via up-regulating spinal mu opioid receptor","volume":"495","author":"Zhang","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2026100811064523700_cit75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-t","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"key":"2026100811064523700_cit76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/cns.12486","article-title":"Preclinical Assessment of Inflammatory Pain","volume":"22","author":"Muley","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"2026100811064523700_cit77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"2026100811064523700_cit78","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1021\/acs.jmedchem.3c01347","article-title":"Structure\u2212Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity","volume":"67","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026100811064523700_cit79","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/bcpt.13566","article-title":"MCRT, a multifunctional ligand of opioid and neuropeptide FF receptors, attenuates neuropathic pain in spared nerve injury model","volume":"128","author":"He","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"2026100811064523700_cit80","doi-asserted-by":"publisher","first-page":"112043","DOI":"10.1016\/j.bbr.2019.112043","article-title":"The influence of a new derivate of kisspeptin-10 -Kissorphin (KSO) on the rewarding effects of morphine in the conditioned place preference (CPP) test in male rats","volume":"372","author":"Gibula-Tarlowska","year":"2019","journal-title":"Behav. Brain Res."},{"key":"2026100811064523700_cit81","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jpain.2019.08.016","article-title":"Spinal DN-9, a Peptidic Multifunctional Opioid\/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects","volume":"21","author":"Wang","year":"2020","journal-title":"J. Pain"},{"key":"2026100811064523700_cit82","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/0024-3205(92)90161-h","article-title":"A specific enzyme assay for aminopeptidase M in rat brain","volume":"51","author":"Gillespie","year":"1992","journal-title":"Life Sci."},{"key":"2026100811064523700_cit83","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/jpet.106.106484","article-title":"Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1","volume":"319","author":"Liu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026100811064523700_cit84","doi-asserted-by":"publisher","first-page":"102440","DOI":"10.1016\/j.npep.2024.102440","article-title":"MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects","volume":"107","author":"Mei","year":"2024","journal-title":"Neuropeptides"},{"key":"2026100811064523700_cit85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High Performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u22122","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"2026100811064523700_cit86","unstructured":"Schrodinger, L. L. C.\n          \n          The PyMOL Molecular Graphics System, Version 3.0.4, 2015."},{"key":"2026100811064523700_cit87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."},{"key":"2026100811064523700_cit88","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"2026100811064523700_cit89","doi-asserted-by":"crossref","unstructured":"Gowers, R. J.; Linke, M.; Barnoud, J.; Reddy, T. J. E.; Melo, M. N.; Seyler, S. L.; Doman\u0301ski, J.; Dotson, D. L.; Buchoux, S.; Kenney, I. M.; MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations. In Proceedings of the 15th Python in Science Conference 2016; Benthall, S., Rostrup, S., Eds., 2016; pp 98\u2212105.","DOI":"10.25080\/Majora-629e541a-00e"},{"key":"2026100811064523700_cit90","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS","volume":"17","author":"Valde\u0301s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c02406","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/22972\/68694476\/jm6c02406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/22972\/68694476\/jm6c02406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:21:37Z","timestamp":1794543697000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/19\/22972\/5441265\/An-Innovative-Auto-Antagonistic-Multi-Target"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":90,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,9,29]]},"published-print":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c02406","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c02406.s005","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}